icon

DeepChek® Assay 13-Plex KB Drug Susceptibility Testing

A Mycobacterium tuberculosis complex drug susceptibility testing assay for sequencing workflows, suited to small, medium, and high-throughput laboratories.

TB Genotyping & Drug Resistance

13-Plex KB Drug Susceptibility Testing

CE-IVDRUO

The DeepChek Assay 13-Plex KB Drug Susceptibility Testing is positioned as an end-to-end CE-IVD solution for Mycobacterium tuberculosis drug susceptibility testing by sequencing.

13-plex workflow MTB complex BacterioChek TB
DeepChek Assay 13-Plex KB Drug Susceptibility Testing

Key Details

  • Single multiplex PCR in vitro diagnostic test for Mycobacterium tuberculosis complex DNA amplification.
  • Designed for unprocessed sputum specimens, concentrated sediments prepared from sputums, or MTB-positive culture.
  • Supports drug susceptibility testing by sequencing across small, medium, and high-throughput laboratory needs.
  • Pairs with BacterioChek TB software for analysis and reporting workflow support.

Workflow Snapshot

Target organismMycobacterium tuberculosis complex
Workflow13-plex multiplex PCR and sequencing
Sample inputSputum, concentrated sputum sediments, or MTB-positive culture
ApplicationDrug susceptibility testing by sequencing
AvailabilityCE-IVD / RUO
SoftwareBacterioChek TB

Ordering Information

ProductReference
DeepChek Assay 13-Plex KB Drug Susceptibility Testing (CE-IVD)128A24
BacterioChek - TB Software (CE-IVD)S-12-023 (TL)

Implementation Note

Use this page for TB drug susceptibility testing requests where the laboratory needs a sequencing-based workflow for Mycobacterium tuberculosis complex.

Back To TB Portfolio

Related TB Solutions